JCR Pharmaceuticals and Modalis Therapeutics advance to next phase of joint gene therapy research

Chime Biologics and Mabgeek completes Process Performance Qualification for MG-K10

LPOXY Therapeutics acquires Xeno Biosciences' key assets

GSK's Nucala approved in China for chronic rhinosinusitis with nasal polyps

Hanx Biopharmaceuticals reports first patient dosed in Phase 1 clinical trial of HX044

Neumora Therapeutics reports Navacaprant's KOASTAL-1 Study data in major depressive disorder

Veeda Group rebrands as 'Veeda Lifesciences'

HUTCHMED announces NDA acceptance in China with priority review for ORPATHYS and TAGRISSO combination in lung cancer

Innovent and Roche agree exclusive global licence for novel DLL3 ADC

Brii Bio acquires BRII-179 IP rights

Kazia Therapeutics updates on paxalisib regulatory pathway after FDA meeting

Veru sells FC2 Female Condom business, focuses on enobosarm

FDA approve Opdivo Qvantig with ENHANZE for subcutaneous use

CARsgen Therapeutics reveals positive CT041-ST-01 (NCT04581473) Phase II clinical trial results

ADC Therapeutics completes phase three trial enrolment for ZYNLONTA-rituximab (Lonca-R) combination in 2L+ Diffuse Large B-Cell Lymphoma